Product status
Clearit regulatory update - safer technologies program submission
ERASER™ System is a Class 2 Medical Device Requiring 510K Submission
Remaining Major Steps to 510K ”Clearance”
Key Market Drivers – Consumer Demands (Client/Patients)
Key Market Drivers – Influencers (Artist/Physicians/Consumers)
Plan Product Offering / Release
Topical cosmetic product that promotes faster,
healthier healing of newly inked tattoos.
• Wholesale to tattoo artist
• Direct to consumers
Exo Bright (2Q 2024)
Topical cosmetic product that restores faded tattoos to their original brightness.
• Direct to consumers
Exo Restore (2Q 2024)
Anti-phagocytosis therapy that augments laser tattoo removal. Potential to reduce the number of treatments by 50%.
• Direct to dermatologists
• Seeking a distribution partner
Fuel (4Q 2024)
First non-thermal, pain free, single treatment, affordable, and healthful tattoo removal system.
• Direct to dermatologists, plastic surgeons, and
tattoo removal franchises